1. Phase II Study of the Antiangiogenic Agent SU5416 in Patients with Advanced Soft Tissue Sarcomas
   John V. Heymach et al, 2004, Clinical Cancer Research CrossRef
2. Insulin-Like Growth Factor Type 1 Receptor Expression Correlates to Good Prognosis in Highly Malignant Soft Tissue Sarcoma
   Jan Åhlén et al, 2005, Clinical Cancer Research CrossRef
3. Anti-Tumor Effect of Apatinib and Relevant Mechanisms in Liposarcoma
   Lixuan Cui et al, 2021, Frontiers in Oncology CrossRef
4. Clinical significance of vascular endothelial growth factor expression and neovascularization in colorectal carcinoma
   Shu Zheng, 2003, World Journal of Gastroenterology CrossRef